128 related articles for article (PubMed ID: 33590779)
21. Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells.
Maeda H; Hosokawa M; Sashima T; Takahashi N; Kawada T; Miyashita K
Int J Mol Med; 2006 Jul; 18(1):147-52. PubMed ID: 16786166
[TBL] [Abstract][Full Text] [Related]
22. Halocynthiaxanthin and fucoxanthinol isolated from Halocynthia roretzi induce apoptosis in human leukemia, breast and colon cancer cells.
Konishi I; Hosokawa M; Sashima T; Kobayashi H; Miyashita K
Comp Biochem Physiol C Toxicol Pharmacol; 2006; 142(1-2):53-9. PubMed ID: 16337836
[TBL] [Abstract][Full Text] [Related]
23. Protective effects of fucoxanthin and fucoxanthinol against tributyltin-induced oxidative stress in HepG2 cells.
Zeng J; Zhang Y; Ruan J; Yang Z; Wang C; Hong Z; Zuo Z
Environ Sci Pollut Res Int; 2018 Feb; 25(6):5582-5589. PubMed ID: 29222657
[TBL] [Abstract][Full Text] [Related]
24. Anticancer effects of marine carotenoids, fucoxanthin and its deacetylated product, fucoxanthinol, on osteosarcoma.
Rokkaku T; Kimura R; Ishikawa C; Yasumoto T; Senba M; Kanaya F; Mori N
Int J Oncol; 2013 Oct; 43(4):1176-86. PubMed ID: 23857515
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effects of fucoxanthinol on the viability of human breast cancer cell lines MCF-7 and MDA-MB-231 are correlated with modulation of the NF-kappaB pathway.
Rwigemera A; Mamelona J; Martin LJ
Cell Biol Toxicol; 2014 Jun; 30(3):157-67. PubMed ID: 24760606
[TBL] [Abstract][Full Text] [Related]
26. Comparative effects between fucoxanthinol and its precursor fucoxanthin on viability and apoptosis of breast cancer cell lines MCF-7 and MDA-MB-231.
Rwigemera A; Mamelona J; Martin LJ
Anticancer Res; 2015 Jan; 35(1):207-19. PubMed ID: 25550553
[TBL] [Abstract][Full Text] [Related]
27. Efficient Preparation of High-Purity Fucoxanthinol by SpyTag-Tailored Active Cholesterol Esterase Aggregates.
Jin W; Yang T; Chen H; Fang H; Chen W; Xie Q; Liu Q; Zhang Y; Hong Z; Zhang G
Mar Drugs; 2022 Nov; 20(11):. PubMed ID: 36421987
[TBL] [Abstract][Full Text] [Related]
28. Biotransformation of fucoxanthinol into amarouciaxanthin A in mice and HepG2 cells: formation and cytotoxicity of fucoxanthin metabolites.
Asai A; Sugawara T; Ono H; Nagao A
Drug Metab Dispos; 2004 Feb; 32(2):205-11. PubMed ID: 14744942
[TBL] [Abstract][Full Text] [Related]
29. Fucoxanthin Prevents Pancreatic Tumorigenesis in C57BL/6J Mice That Received Allogenic and Orthotopic Transplants of Cancer Cells.
Murase W; Kamakura Y; Kawakami S; Yasuda A; Wagatsuma M; Kubota A; Kojima H; Ohta T; Takahashi M; Mutoh M; Tanaka T; Maeda H; Miyashita K; Terasaki M
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948416
[TBL] [Abstract][Full Text] [Related]
30. Fucoxanthin bioavailability from fucoxanthin-fortified milk: In vivo and in vitro study.
Mok IK; Lee JK; Kim JH; Pan CH; Kim SM
Food Chem; 2018 Aug; 258():79-86. PubMed ID: 29655757
[TBL] [Abstract][Full Text] [Related]
31. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
32. Correlation between S100A11 and the TGF-β
Ji YF; Li T; Jiang F; Ni WK; Guan CQ; Liu ZX; Lu CH; Ni RZ; Wu W; Xiao MB
Mol Cell Biochem; 2019 Jan; 450(1-2):53-64. PubMed ID: 29922945
[TBL] [Abstract][Full Text] [Related]
33. Activation of the PI3K/Akt pathway mediates bone morphogenetic protein 2-induced invasion of pancreatic cancer cells Panc-1.
Chen X; Liao J; Lu Y; Duan X; Sun W
Pathol Oncol Res; 2011 Jun; 17(2):257-61. PubMed ID: 20848249
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells.
Xu Z; Zhang Y; Jiang J; Yang Y; Shi R; Hao B; Zhang Z; Huang Z; Kim JW; Zhang G
BMC Cancer; 2010 Apr; 10():161. PubMed ID: 20423485
[TBL] [Abstract][Full Text] [Related]
35. Lysophosphatidic acid stimulates activation of focal adhesion kinase and paxillin and promotes cell motility, via LPA1-3, in human pancreatic cancer.
Liao Y; Mu G; Zhang L; Zhou W; Zhang J; Yu H
Dig Dis Sci; 2013 Dec; 58(12):3524-33. PubMed ID: 24061591
[TBL] [Abstract][Full Text] [Related]
36. Marine bioactive compound dieckol induces apoptosis and inhibits the growth of human pancreatic cancer cells PANC-1.
Xu JW; Yan Y; Wang L; Wu D; Ye NK; Chen SH; Li F
J Biochem Mol Toxicol; 2021 Feb; 35(2):e22648. PubMed ID: 33051972
[TBL] [Abstract][Full Text] [Related]
37. Radical scavenging and singlet oxygen quenching activity of marine carotenoid fucoxanthin and its metabolites.
Sachindra NM; Sato E; Maeda H; Hosokawa M; Niwano Y; Kohno M; Miyashita K
J Agric Food Chem; 2007 Oct; 55(21):8516-22. PubMed ID: 17894451
[TBL] [Abstract][Full Text] [Related]
38. Fucoxanthin and Colorectal Cancer Prevention.
Terasaki M; Kubota A; Kojima H; Maeda H; Miyashita K; Kawagoe C; Mutoh M; Tanaka T
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069132
[TBL] [Abstract][Full Text] [Related]
39. Grape proanthocyanidin inhibit pancreatic cancer cell growth in vitro and in vivo through induction of apoptosis and by targeting the PI3K/Akt pathway.
Prasad R; Vaid M; Katiyar SK
PLoS One; 2012; 7(8):e43064. PubMed ID: 22905202
[TBL] [Abstract][Full Text] [Related]
40. Fucoxanthin, a Marine Carotenoid, Attenuates
Lin J; Yu J; Zhao J; Zhang K; Zheng J; Wang J; Huang C; Zhang J; Yan X; Gerwick WH; Wang Q; Cui W; He S
Oxid Med Cell Longev; 2017; 2017():6792543. PubMed ID: 28928905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
